Kiely P - Search Results

1

Understanding occult hepatitis C infection.

An T, Dean M, Flower R, Tatzenko T, Chan HT, Kiely P, Faddy HM. An T, et al. Among authors: kiely p. Transfusion. 2020 Sep;60(9):2144-2152. doi: 10.1111/trf.16006. Epub 2020 Aug 15. Transfusion. 2020. PMID: 33460181 Review.

2

Characteristics of hepatitis C-positive blood donors in Victoria, Australia.

Wong PY, Dodd R, Kiely P, Carroll C, Whyte G. Wong PY, et al. Among authors: kiely p. Transfus Med. 1999 Mar;9(1):15-9. doi: 10.1046/j.1365-3148.1999.009001015.x. Transfus Med. 1999. PMID: 10216901 Clinical Trial.

3

Results of HCV screening of volunteer blood donors with a chemiluminescent immunoassay and a second- or third-generation EIA: overlap of false-positive reactivity and its impact on donor management.

Kiely P, Wilson D. Kiely P, et al. Transfusion. 2000 May;40(5):580-4. doi: 10.1046/j.1537-2995.2000.40050580.x. Transfusion. 2000. PMID: 10827263

4

Anti-HCV confirmatory testing of voluntary blood donors: comparison of the sensitivity of two immunoblot assays.

Kiely PR, Eliades LA, Kebede M, Stephenson MD, Jardine DK. Kiely PR, et al. Transfusion. 2002 Aug;42(8):1053-8. doi: 10.1046/j.1537-2995.2002.00153.x. Transfusion. 2002. PMID: 12385418

5

Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT.

Seed CR, Cheng A, Ismay SL, Bolton WV, Kiely P, Cobain TJ, Keller AJ; Virology Subcommittee of the National Donor and Product Safety Committee, Australian Red Cross Blood Service. Seed CR, et al. Among authors: kiely p. Transfusion. 2002 Oct;42(10):1365-72. doi: 10.1046/j.1537-2995.2002.00204.x. Transfusion. 2002. PMID: 12423522

6

Analysis of voluntary blood donors with biologic false reactivity on chemiluminescent immunoassays and implications for donor management.

Kiely P, Stewart Y, Castro L. Kiely P, et al. Transfusion. 2003 May;43(5):584-90. doi: 10.1046/j.1537-2995.2003.00386.x. Transfusion. 2003. PMID: 12702178

7

The significance of third-generation HCV RIBA-indeterminate, RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassays.

Kiely P, Kay D, Parker S, Piscitelli L. Kiely P, et al. Transfusion. 2004 Mar;44(3):349-58. doi: 10.1111/j.1537-2995.2003.00671.x. Transfusion. 2004. PMID: 14996191

8

Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA.

Margaritis AR, Brown SM, Seed CR, Kiely P, D'Agostino B, Keller AJ. Margaritis AR, et al. Among authors: kiely p. Transfusion. 2007 Oct;47(10):1783-93. doi: 10.1111/j.1537-2995.2007.01343.x. Transfusion. 2007. PMID: 17880602

9

Analysis of sample-to-cutoff ratios on chemiluminescent immunoassays used for blood donor screening highlights the need for serologic confirmatory testing.

Kiely P, Walker K, Parker S, Cheng A. Kiely P, et al. Transfusion. 2010 Jun;50(6):1344-51. doi: 10.1111/j.1537-2995.2009.02572.x. Epub 2010 Jan 22. Transfusion. 2010. PMID: 20113456

10

No evidence of a significantly increased risk of transfusion-transmitted human immunodeficiency virus infection in Australia subsequent to implementing a 12-month deferral for men who have had sex with men.

Seed CR, Kiely P, Law M, Keller AJ. Seed CR, et al. Among authors: kiely p. Transfusion. 2010 Dec;50(12):2722-30. doi: 10.1111/j.1537-2995.2010.02793.x. Transfusion. 2010. PMID: 20663106

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

391 results

Search Page